marketinsider

Unveiling Capital Southwest’s Second Quarter 2023 Operating Results: A Sneak Peek and Important Dates for Earnings Release and Conference Call!

Capital Southwest Announces Preliminary Estimate of Second Quarter 2023 Operating Results Overview DALLAS, Oct. 07, 2022 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” the “Company” or “we”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to…

Read More

Join Us at the 2022 PDA Pharmaceutical Microbiology Conference: Discover the Latest Innovations from Rapid Micro Biosystems!

Join Us at the 2022 PDA Pharmaceutical Microbiology Conference: Discover the Latest Innovations from Rapid Micro Biosystems! Get ready for an experience like no other! Exciting news for all those in the pharmaceutical industry! Are you passionate about staying ahead of the curve in the world of pharmaceutical microbiology? Do you want to be at…

Read More

Revitalizing Communities: Community Redevelopment Inc. Unveils Board of Directors’ Impactful Decisions

Annapolis based Community Redevelopment Highlights Plans to Enhance Stockholder Value and Updates Board Governance Annapolis, Oct. 03, 2022 GLOBE NEWSWIRE – Community Redevelopment, Inc. (CRDV), today announced corporate governance actions consistent with the Company’s efforts to drive long-term value creation for all stakeholders. In a Board of Director’s Meeting… Community Redevelopment, Inc. Announces Board of…

Read More

ATFX Welcomes Phil Muldoon as New Institutional Sales Director: A Veteran Leader in the Finance Industry

ATFX Welcomes Phil Muldoon as New Institutional Sales Director: A Veteran Leader in the Finance Industry ATFX announced that Phil Muldoon, an industry leader, had officially joined the company’s institutional business as Institutional Sales Director. As the brand continues to expand its global influence, ATFX has partnered with Phil, an experienced leader, to execute its…

Read More

Meet the New Boss: Urica Therapeutics Welcomes Dr. Jay D. Kranzler as Chairman and CEO!

Welcome to the Quirky World of Urica Therapeutics! Meet the Newest Addition to the Urica Therapeutics Family Urica Therapeutics, Inc. has recently announced the appointment of seasoned biotech executive, Jay D. Kranzler, M.D., Ph.D., as their latest addition to the team. This exciting news comes as a positive development for the company, which is dedicated…

Read More

Attention Stitch Fix Investors: Don’t Miss This Deadline! Rosen, Top-Ranked Investor Counsel, Urges You to Secure Legal Representation for Securities Class Action Against SFIX

Attention Stitch Fix Investors: Don’t Miss This Deadline! Rosen, Top-Ranked Investor Counsel, Urges You to Secure Legal Representation for Securities Class Action Against SFIX Are you a Stitch Fix investor? If so, you may want to pay attention to this important deadline. Rosen Law Firm, a global investor rights law firm, is reminding purchasers of…

Read More

Unlocking Potential: Biofrontera Inc. to Showcase at the ROTH Inaugural Healthcare Opportunities Conference

Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale…

Read More